Company intelligence / Profile preview
Cipla
Mumbai, Maharashtra, Indiacipla.com ↗
- Ownership
- Public · CIPLA
- Employees
- ~25000
- Development stage
- Other
01
Overview
Cipla has a broad commercial portfolio with over 1,500 products, including generics and branded medicines across more than a dozen therapeutic areas. It leads in antiretroviral drug manufacturing globally and pioneered affordable triple therapy for HIV/AIDS. Recent clinical innovation includes pediatric fixed-dose ARV combinations developed with global partners.
- Therapeutic areas
- PulmonologyCardiovascularEndocrinologyDermatologyOncologyNeurologyInfectious Diseases
- Modalities
- Small molecules (generics and branded drugs)BiosimilarsInhalation therapies/devices (e.g., metered-dose inhalers)Fixed-dose combinations
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Gilead Sciences – Remdesivir licensing for COVID treatment in IndiaTakeda Pharmaceutical Company – Vonoprazan commercialization licenseFormosa Pharmaceuticals – Clobetasol Propionate Ophthalmic Suspension commercialization agreementDrugs for Neglected Diseases initiative (DNDi), Unitaid – Pediatric ARV development partnership
04
Financials
- Market cap
- $12.1B
- Total revenue
- $3B
- Enterprise value
- $11.1B
Beyond the preview
Go deeper on Cipla.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cipla.